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Context inﬂuences on TALE–DNA binding
revealed by quantitative proﬁling
Julia M. Rogers1,2,*, Luis A. Barrera1,2,3,4,*, Deepak Reyon5,6,7,8, Jeffry D. Sander5,6,7,8, Manolis Kellis4,
J. Keith Joung5,6,7,8 & Martha L. Bulyk1,2,3,9
Transcription activator-like effector (TALE) proteins recognize DNA using a seemingly simple
DNA-binding code, which makes them attractive for use in genome engineering technologies
that require precise targeting. Although this code is used successfully to design TALEs to
target speciﬁc sequences, off-target binding has been observed and is difﬁcult to predict.
Here we explore TALE–DNA interactions comprehensively by quantitatively assaying the
DNA-binding speciﬁcities of 21 representative TALEs to B5,000–20,000 unique DNA
sequences per protein using custom-designed protein-binding microarrays (PBMs). We ﬁnd
that protein context features exert signiﬁcant inﬂuences on binding. Thus, the canonical
recognition code does not fully capture the complexity of TALE–DNA binding. We used the
PBM data to develop a computational model, Speciﬁcity Inference For TAL-Effector Design
(SIFTED), to predict the DNA-binding speciﬁcity of any TALE. We provide SIFTED as a
publicly available web tool that predicts potential genomic off-target sites for improved TALE
design.
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T
he discovery of Transcription Activator-Like Effector
(TALE) proteins has enabled the development of a host
of genome and epigenome editing technologies1–8.
Naturally occurring as bacterial virulence factors, TALE
proteins harbour an array of repeats, each 33 or 34 amino acids
in length9,10. The sequence of the repeats is highly conserved
except at the hypervariable positions 12 and 13, termed the repeat
variable diresidues (RVDs). The amino acids at the RVD
positions determine which DNA base is preferred, and each
repeat in the TALE contacts one base in the target site. This led to
a simple one-to-one ‘TALE code’ that uniquely predicts the
optimal DNA target from the sequence of RVDs within the repeat
array9,10. The most commonly used RVDs are NI (Asparagine,
Isoleucine), HD (Histidine, Aspartic Acid), NN (Asparagine,
Asparagine) and NG (Asparagine, Glycine), used to target A, C, G
and T, respectively. Co-crystal structures have shown the
mechanism of this one-to-one code, in which the TALE protein
wraps around the DNA in a helical structure with each repeat
contacting a single base11,12. In addition, contacts between the
N-terminal region (NTR) of the TALE protein and DNA specify a
preference for a thymine base 50 to the DNA target site13.
This simple TALE recognition code allows for any DNA site
preceded by a T to be targeted by a TALE protein designed
with the corresponding repeat sequence. Therefore, the TALE
DNA-binding domain has been adapted for use in many
technologies that require precise targeting of genomic loci. For
example, dimeric TALE nucleases (TALENs) have been used in
various organisms and cell lines to knock out genes by the
introduction of indels or to create speciﬁc mutations2. Fusions of
TALE monomers to transcriptional activation or repression
domains can create artiﬁcial transcription factors, which
have been shown to strongly and cooperatively modulate gene
expression4,6,8. Monomeric TALE fusions to chromatin-
modifying enzymes can introduce speciﬁc DNA or histone
modiﬁcations at target loci, resulting in changes in expression of
the associated genes3,5. TALEs can also be used to pull down
speciﬁc genomic regions to identify bound proteins1. In addition,
TALEs fused to ﬂuorescent proteins can be used to visualize
chromatin dynamics in live cells1,7. Although other technologies,
(for example, CRISPR-Cas9) have also been developed for some
of these targeting applications14, TALE versus dCas9 fusions
might be more effective in different applications and having
both technologies in the toolkit for genome engineering is likely
optimal.
Despite these successes in genome editing, off-target activities
of TALE fusions have been described but have proven difﬁcult
to predict15–21. Experimental approaches have identiﬁed off-
target TALEN effects20, but no technology has directly measured
off-target binding for monomeric TALE fusions15–17,22. Here, we
deﬁne TALE protein speciﬁcity as the relative binding energies of
the protein to different DNA sequences. Computational tools that
use the speciﬁcities of the individual repeats to predict
the speciﬁcity of the whole protein have been developed to
predict off-target binding sites23,24; these approaches assume
that each repeat independently contributes to the speciﬁcity of the
whole protein and that each instance of a given repeat RVD type
has the same preference for its intended base. However, a
quantitative analysis of TALE afﬁnity indicated that repeat
position within the repeat array affects RVD speciﬁcity, indicating
a potential role for repeat context in predicting speciﬁcity25.
Other studies have also found that total protein length affects
speciﬁcity20. In addition, particular repeat types may contribute
differentially to overall protein speciﬁcity. One study showed that
some repeats are more active when assembled into a TALE
activator, leading to the distinction between strong (NN and HD)
and weak (NI and NG) repeats, although the relationship between
RVD strength and speciﬁcity is unclear26. Altogether, these
ﬁndings suggest that TALE–DNA-binding speciﬁcity may be
more complex than previously thought, but these effects have yet
to be assayed comprehensively and quantitatively.
Tools used to predict TALE speciﬁcity and to identify likely
genomic targets have not kept pace with these increasing, albeit
qualitative, reports on TALE–DNA recognition. Some computa-
tional tools, such as PROGNOS and Talvez, have incorporated
context effects qualitatively in predicting TALEN pair off-target
sites, but assume all repeat types are affected identically by
context27,28. A recently described approach used a selection-based
cleavage assay to characterize a TALEN pair’s speciﬁcity proﬁle in
order to identify potential TALEN off-target sites; however, that
study did not provide a predictive model, but instead required
that the speciﬁcity of each TALEN pair be determined
experimentally20. As such, there remains a need for a purely
computational tool that quantitatively incorporates these context
effects in predicting TALE speciﬁcity, and thus, off-target binding
sites.
In this study, we perform a quantitative, in-depth examination
of context effects on RVD speciﬁcity in order to infer general
rules for highly accurate prediction of the DNA sequence-
speciﬁcity of any TALE protein. We design custom protein-
binding microarrays (PBMs) to investigate the DNA-binding
speciﬁcities of 21 TALE proteins that comprise all possible pairs
of repeat types. The custom PBMs contain probes in which all
possible mono- and di-nucleotide substitutions within the TALE
target sites are represented. The resulting quantitative binding
data for the TALE proteins to B20,000 unique DNA sequences
allow us to quantify the effects of TALE repeat array length,
repeat position and neighbouring repeat types on the speciﬁcity of
each RVD, henceforth referred to as RVD speciﬁcity. We use the
PBM-derived quantitative binding data to develop a computa-
tional model (Speciﬁcity Inference For TAL-Effector Design or
SIFTED) that incorporates these context effects to predict both
the DNA-binding speciﬁcity and the potential off-target sites of
any TALE protein without requiring any additional PBM
experiments. We implement this model in a publicly available,
user-friendly suite of web tools at http://thebrain.bwh.harvar-
d.edu/sifted.html.
Results
Custom-designed PBMs to assay TALE–DNA-binding speciﬁcity.
To develop a more in-depth, quantitative understanding of TALE–
DNA recognition, we determined the DNA-binding speciﬁcities of
21 representative TALE proteins using custom-designed PBMs29–31
(Fig. 1a,b, Supplementary Table 1 and Supplementary Data 1). We
selected these proteins to allow us to examine the effects of different
protein features on speciﬁcity. In particular, these proteins represent
all possible consecutive repeat pairs and thus allow us to assay all
possible direct neighbour effects on RVD speciﬁcity (Fig. 1a)32. In
addition, this set spans protein lengths from 8.5 to 18.5 repeats
(targeting sites 10–20 base pairs in length); these lengths typically
have been used in the design of monomeric TALE fusion proteins
for genomic applications4.
PBMs are double-stranded DNA microarrays that permit
rapid, highly parallel measurement of the binding of a protein of
interest to tens of thousands of unique DNA sequences in
replicate, allowing for a much richer picture of TALE–DNA
recognition than has resulted from prior studies. As the vast
majority of our selected TALE proteins were designed to
recognize sequences longer than those on the previously designed
‘all 10-mer’ universal PBM design30, we designed custom TALE-
PBMs for this study. Each probe sequence was represented on at
least eight replicate spots on the arrays. The initial custom array
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was designed to broadly assay the binding preferences of our
representative set of TALE proteins. Subsequently, additional
arrays were designed to validate particular observations about
TALE speciﬁcity, as discussed below (Supplementary Fig. 1 and
Supplementary Note 1).
We determined the DNA-binding speciﬁcities of each TALE
protein using probe sets that contain each protein’s target site as
predicted by the canonical TALE code9, as well as variants
thereof, ﬂanked by constant DNA sequence and situated at a ﬁxed
position within the probe relative to the slide surface
(Supplementary Note 1). The constant ﬂanking sequence was
predicted to not be bound by any of the TALEs tested in this
study. For each protein, we measured binding to between 160 and
320 variant target sites that cover all possible adjacent
dinucleotide substitutions. Although the absolute Kd of a
protein–DNA interaction cannot be determined from a single
PBM experiment33, by measuring how much each substitution
changes protein binding to the DNA probe, we can infer changes
in binding free energy (DDG values) for each possible substitution
within the target site.
From these DDG values, we derived a position weight matrix
(PWM) for the protein (Fig. 2a and Supplementary Fig. 2). The
inferred PWMs were consistent across experimental replicates
and across PBM experiments performed at different concentra-
tions of TALE proteins (Supplementary Fig. 3). Our PWMs
accurately predict the 60-base-pair probe signal intensities, with a
median R2 of 0.959 (Fig. 2b and Supplementary Fig. 4), indicating
that they perform well as accurate models of TALE–DNA-
binding speciﬁcity.
The fact that our PWMs explain binding well suggests that an
additive binding model with independence between the nucleo-
tides in the TALE target site is quite accurate. To test if this
nucleotide independence extends beyond two adjacent mis-
matches, we designed a probe set that contains up to ﬁve
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nonadjacent mismatches in the target site (Supplementary Note 1
and Supplementary Fig 1). The PWM models derived from the
dinucleotide substitution probes accurately predicted binding to
these sequences with additional mismatches (median R2 greater
than 0.9 for all numbers of substitutions tested), indicating that
the simple PWM models with mononucleotide independence
perform well in modelling TALE–DNA-binding speciﬁcity
(Supplementary Fig. 5). These results are roughly consistent with
a recent study of TALEN pair speciﬁcity determined by a
selection-based cleavage assay, in which general independence in
DNA recognition was observed; however, our data support a fully
independent model of TALE–DNA binding, rather than a model
with slightly increased tolerance for adjacent mismatches20.
Modelling repeat context improves speciﬁcity prediction.
Although we observed mononucleotide independence within
TALE target sites, we found that the protein–DNA interactions of
a given repeat are inﬂuenced by its context. In other words, the
energetic parameters of a given TALE–DNA contact are not
affected by neighbouring nucleotide changes, but they are affected
by the repeat context. Intriguingly, even within a single TALE
protein, different occurrences of the same repeat type can exhibit
very different speciﬁcities. For example, in TAL2009, repeats 7
and 10 were both designed with the HD RVD to target C, but
within the context of the TAL2009 protein each exhibits sub-
stantially different relative preferences for C as compared with
other nucleotides (Fig. 2a). Typically, the highest scoring probe
corresponded to the target sequence predicted by the canonical
TALE code; however, we observed multiple cases (for example,
TAL2024) where a TALE protein bound mismatched sequences
with comparable binding strength, hereafter referred to as afﬁnity.
Moreover, some TALEs (for example, TAL2009) even preferred a
mismatched sequence to the predicted optimal target sequence;
this most frequently involved an NN RVD, which can target
both a G and an A in different contexts (for example, see
repeats 3 and 6 in Fig. 2a)10. Altogether, these results highlight
that the simple one-to-one TALE code is not sufﬁcient to
accurately predict DNA-binding speciﬁcity.
As our results suggested that interactions between repeats
modulate their individual RVD speciﬁcities, we modelled the
PBM data to predict TALE speciﬁcity considering the context of
each repeat in a TALE protein (Fig. 1c). We named our model
and its associated software tools SIFTED (Speciﬁcity Inference
For TAL-Effector Design). In addition to modelling the intrinsic
speciﬁcity of each RVD, SIFTED considers a variety of repeat
context features, including the number of repeats in the protein,
each repeat’s position within the repeat array, and the
immediately adjacent N- and C-terminal neighbouring repeat
types. The NTR, which speciﬁes the preference for the 50 T in the
binding site, was also included in the model and was treated
equivalently to a repeat, except for the omission of its position
and length features.
We trained the SIFTED model by performing a linear
regression with Elastic Net regularization, using the DDG values
inferred for each protein as the input data34. To prevent
overﬁtting and to assess performance, we used a nested leave-
one-out cross-validation strategy. Brieﬂy, one protein was held
out from the data set in an iterative manner. The remaining
proteins were divided into training and test sets, which were used
to derive parameter values and to control the complexity of the
model (Supplementary Fig. 6). The predicted PWM for each of
the 21 TALE proteins was obtained from the model trained on
data from the remaining 20 proteins in our data set (Fig. 1a). For
speciﬁcity predictions of proteins not in our data set (for example,
TALEN pairs), the regression was performed on the full data set
(no proteins excluded) and the resulting model was used to make
PWM predictions.
To assess how well our model explains binding, we used the
PWMs obtained from the cross-validated SIFTED model to
predict PBM probe signal intensities. The SIFTED PWMs
accurately predict the probe-level PBM-binding data (median
R2¼ 0.877). In addition, SIFTED outperformed the speciﬁcity
models from other available computational tools designed to
predict off-target sites in explaining the PBM data (Po10 6,
Wilcoxon signed-rank test; Fig. 3a). Two of these tools, TALE-NT
2.0 (ref. 23) and TALgetter24, do not consider any context effects.
Others, such as PROGNOS27 and Talvez28, include context
effects on an RVD’s speciﬁcity only as discrete penalties. In
contrast, SIFTED models context effects quantitatively and also
allows each repeat type (that is, NI, HD, NN and NG) to be
inﬂuenced differently by its context. These detailed context
parameters in our model are keys to its success; the full model
predictions from SIFTED are more accurate (Po10 6, Wilcoxon
signed-rank test) than those of an RVD-only model that
represents the canonical, one-to-one TALE–DNA recognition
code (median R2¼ 0.798; Fig. 4).
We validated that our SIFTED model can predict off-array
binding afﬁnity measurements (Kd values) more accurately than
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other published tools35 (Fig. 3b). Although PWMs cannot be used
to predict absolute dissociation constants, they are able to predict
the afﬁnity of a sequence relative to that of the optimal binding
site (that is, relative Kd values)36. The full SIFTED model
performed signiﬁcantly better than PROGNOS, TALE-NT 2.0,
TALgetter, Talvez or a reduced SIFTED model with no context
effects in predicting relative Kd values for 1 protein and 18 DNA
sequences35.
Quantitative modelling of context effects on RVD speciﬁcity.
As context effects contributed signiﬁcantly to the predictive power
of our model, we investigated in greater depth how length, posi-
tion and neighbouring repeats each affect speciﬁcity. Although our
baseline RVD speciﬁcities (Fig. 5a) largely agree with previous
studies9 (for example, NN is the least speciﬁc RVD and can target
both G and A), in the SIFTED model these speciﬁcities are
modulated by the protein context of each instance of the repeat.
Our data are consistent with previous reports that longer
proteins tolerate more mismatches in their target sites20 (Fig. 5b).
Our comprehensive proﬁling also revealed that NN and NG
repeats are affected more strongly by protein length than are
either NI or HD. In addition, our set of proteins included two
proteins of different lengths designed to target overlapping sites.
The longer protein (TAL2073) is less speciﬁc overall (that is,
lower total information content) than the shorter protein
(TAL2043; Supplementary Fig. 2), directly supporting our
overall ﬁnding that increased TALE protein length diminishes
RVD speciﬁcity.
Repeat position within the repeat array also affects the
speciﬁcity of C-terminal repeats that target the 30 end of the
DNA binding site, resulting in their being more tolerant to
substitutions than N-terminal RVDs. To test this modelling
result, we designed a custom PBM that included probes
containing clusters of three nucleotide substitutions located at
either the 50 or 30 end of the target site (Supplementary Fig. 1 and
Supplementary Note 1). In general, substitutions at the 50 end
impaired binding more than substitutions at the 30 end (Po0.05,
Wilcoxon signed-rank test; Supplementary Fig. 7), supporting
prior observations from reporter assays25,37. Talvez and
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PROGNOS model this polarity effect discretely as a constant
decrease in speciﬁcity after a certain position in the repeat array
for all repeat types27,28. In contrast, SIFTED continuously models
the decrease in speciﬁcity over the length of the protein and
allows different repeat types to be affected to different extents
(Fig. 5b).
Last, we observed that a repeat’s speciﬁcity is impacted by the
identity of the immediately adjacent N- or C- terminal repeat
(Fig. 5c). Such local context effects previously have been observed
only for the 50 T preference, which is more important for binding
when the ﬁrst repeat is an HD38. We also observed the inﬂuence
of HD in the ﬁrst position, but found an even stronger effect
when the ﬁrst repeat is an NN. In addition, we observed
neighbour context effects between repeats within the protein. For
example, the NN repeat is more speciﬁc for targeting a G when
the NI repeat is either N- or C-terminal to it; however, it is much
less speciﬁc for G when it is positioned at the C-terminal end of a
TALE repeat array.
We found that a particular repeat type can exert different
effects as an N- or C-terminal neighbour (Fig. 5c). PROGNOS
includes a parameter to reduce an RVD’s speciﬁcity when it is
next to a strong RVD (NN or HD), positing that a stronger
neighbouring interaction may allow for greater mismatch
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tolerance26,27; however, it does not distinguish between N- and
C-terminal neighbours. The neighbour effects we found are more
complex, and in fact, the strong RVDs do not always decrease
speciﬁcity. The complexities of the neighbouring effects are
captured quantitatively in SIFTED; each of the four RVDs as well
as the 50 T preference are modelled as being affected differently by
its N- and C-terminal neighbouring repeats.
These observations of context effects can be condensed into
some simple guidelines for TALE design (Table 1). Certain repeat
combinations (for example, NI–NI) are predicted to have
increased speciﬁcity, whereas others (for example, NG as the
N-terminal repeat) can make an RVD more tolerant to mismatch
and therefore should be avoided. However, when designing TALE
proteins, one must ultimately consider all the context effects in
the protein, as well as the prevalence of potential off-target sites in
the genome. As such, we tested if the SIFTED model could
accurately predict genomic off-target sites, and therefore could be
used to guide TALE protein design.
Predicting TALE off-target sites using SIFTED. To assess
whether SIFTED can predict genomic off-target sites for TALE
proteins that have not been assayed by PBMs, we examined a data
set of in vivo TALE reporter activity22. SIFTED had the highest
median performance of the ﬁve tools tested (Fig. 3c).
Although SIFTED was designed to predict TALE monomer
speciﬁcity, we also tested its ability to predict TALEN binding by
examining a large data set of TALEN activity in cells20. We
derived the speciﬁcities of TALEN pairs from the speciﬁcities of
the component monomers predicted by SIFTED. The PWMs
from SIFTED resulted in better sensitivity and speciﬁcity than
those from any of the other models in distinguishing genomic
target sites that showed nuclease activity from those that did not
(Fig. 3d and Supplementary Data 2). The area under the receiver
operating characteristic curve statistic was used to quantify the
ability of the ﬁve tools to distinguish target from non-target sites
across all possible score thresholds. SIFTED demonstrated
superior sensitivity and speciﬁcity across most thresholds.
In addition, we considered that a typical TALE user might
investigate about 20 off-target sites when analysing the speciﬁcity
of their designed protein in their genome of interest. To provide a
performance comparison for this typical use case, we investigated
how many of the top 20 off-target sites predicted by these tools
have been identiﬁed as TALEN pair off-targets in vivo
(Supplementary Fig. 8a,b) or were among the 20 off-targets with
the highest measured in vivo activity (Supplementary Fig 8c).
Again, SIFTED performed better than the other tools, demon-
strating higher sensitivity by predicting more of the true off-
targets than the other tools (Supplementary Fig. 8b and
Supplementary Data 2).
Prediction of genomic off-targets with SIFTED web tool.
SIFTED was the top-performing model overall, highlighting the
value of incorporating repeat context effects in predicting speci-
ﬁcity. Although other tools may perform comparably to SIFTED
in a speciﬁc application, SIFTED was the only tool that was
consistently a top performer across the wide range of benchmarks
of predictive performance (Fig. 3 and Supplementary Fig. 8).
Given the success of SIFTED in predicting off-target binding,
we developed it into a web-based suite of tools to aid in TALE
design implemented on the Galaxy platform39–41 at http://
thebrain.bwh.harvard.edu/sifted.html. We provide stand-alone
tools for individual tasks, such as predicting the speciﬁcity and
genomic binding sites of a user-speciﬁed TALE, as well as a
pipeline that combines various tools to automate the process of
designing a TALE to target a particular genomic region. The
complete pipeline takes a user-deﬁned genomic target region as
input, and then (i) identiﬁes candidate TALEs to target that input
region, (ii) predicts the candidates’ speciﬁcities, (iii) ﬁnds
instances of off-target sites in a user-speciﬁed genome and
(iv) outputs a list of candidate TALE proteins ranked by their
off-target binding potential, thus allowing the user to select the
best candidate protein.
Discussion
By analysing TALE proteins of different lengths and containing
all possible consecutive pairs of repeats, we were able to identify
the inﬂuence of repeat context on DNA-binding speciﬁcity. In
contrast to other studies that used cell-based TALEN activity as a
measurement of TALE speciﬁcity35, our experimental design
allowed us to directly assay the intrinsic binding properties of
TALE monomers. We measured a total of B200,000 binding
interactions between 21 TALE proteins and B5,000–20,000
unique DNA sequences per protein using custom-designed
PBMs. Importantly, the resulting data set allowed us to develop
a model to predict TALE speciﬁcity for any candidate TALE
protein without requiring any additional experimental analysis.
Our results highlight that RVD speciﬁcity is not determined
simply by what base a particular RVD will bind, but also which
bases it strongly disfavours. This information could be useful in
designing TALEs for allele-speciﬁc applications, such as rapid,
spatially resolved genotyping of patient samples through binding
of ﬂuorescently tagged, allele-speciﬁc TALEs. The HD RVD has
the greatest power to discriminate between two alleles: it prefers
binding to a C and strongly disfavours binding to a G. Therefore,
targeting an allele where there is a C/G SNP may lead to stronger
discrimination between the two alleles.
We found that longer TALEs are generally less speciﬁc than
shorter TALEs. This effect could be due to excess DNA-binding
energy in TALE proteins with many repeats20. The mechanism of
the context effects on RVD speciﬁcity remains to be determined.
An ability to tolerate some binding site mismatches may allow a
TALE protein from xanthomonad pathogens to overcome
mutations in host genomic target sites, as the plant host may
be under selection to escape xanthomonad infection. However,
Table 1 | Target site guidelines for TALE design.
Target site guideline Rationale
Target A runs The NI repeat is more speciﬁc with NI as its N- or C- terminal neighbour
Avoid 30 A, C or G The NI, HD and NN repeats are less speciﬁc at the C-terminal end
Avoid T in ﬁrst position Both the 50 T preference and the NG repeat are less speciﬁc if the ﬁrst repeat is NG
Use the SIFTED web tool to identify off-targets The web tool incorporates all context effects and can evaluate effective speciﬁcity in the genome.
SIFTED, Speciﬁcity Inference for TAL-Effector Design; TALE, transcription activator-like effector.
The observed context effects were used to create simple guidelines to incorporate when designing TALEs. However, we recommend using the SIFTED web tool to predict speciﬁcity and locate potential
off-target sites when designing a TALE protein to target a genomic region.
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TALEs with very low speciﬁcity may lead to potential negative
effects on virulence because of additional binding in the host
genome42. Thus, the speciﬁcity of TALE proteins may have been
strongly shaped by the complex interactions between host and
pathogen.
SIFTED predicts that some DNA sequences should be targeted
with greater speciﬁcity, which could be interpreted as guidelines
for TALE design (Table 1). Interestingly, some of these guidelines
would contradict published guidelines that were developed as part
of the SAPTA tool for designing more active TALEN pairs43. For
example, although we predict that A-runs can be targeted with
high speciﬁcity by TALE monomers, SAPTA predicts that
TALENs targeting A-runs will have lower nuclease activity. The
discrepancies in these guidelines and results might reﬂect
different rules affecting the binding of monomeric TALEs
versus dimeric TALENs. Alternatively, it is possible that a
trade-off exists between optimizing activity and speciﬁcity in
designing TALENs. Previous reports have found no correlation
between activity and afﬁnity35. This lack of correlation between
in vitro binding and different cell-based activity measurements
might be due to other genomic features in cells, such as the
chromatin state and competition with other transcription factors
at the target and off-target sites. Ultimately, in designing TALEs,
the intrinsic speciﬁcity of the protein must be considered in light
of its potential off-target binding sequences in the genome. For
example, the decreasing speciﬁcity of longer TALEs may be
compensated by longer target sites being more rare in the
genome, thus increasing the effective speciﬁcity of a protein20.
SIFTED can both model protein speciﬁcity as well as identify
genomic off-target sites, revealing the effective speciﬁcity of a
TALE, so users can choose the most speciﬁc TALE protein for
their particular application.
Future studies will be required to identify chromatin features
that might modulate binding speciﬁcity in vivo. In addition,
the speciﬁcities of other alternative RVDs (for example, NH to
target G) could be studied to enable design of TALE proteins
with higher sequence speciﬁcity. An improved understanding of
TALE–DNA binding should allow for development of more
precise genome engineering tools.
Methods
Cloning of TALE proteins. TALEN expression vectors32 were digested with SacII
and BamHI to obtain the DNA-binding domain comprising the D152 N-terminal
domain, the RVD repeats, and the þ 63 C-terminal domain. This fragment was
ligated into a modiﬁed pDONR221 vector (Invitrogen), with SacII and BamHI
restriction sites internal to attL recombination sites, to create Gateway-compatible
TALE Entry clones. The TALE constructs were then transferred by Gateway
recombinational cloning into the pDEST15 expression vector, which adds an
N-terminal glutathione S-transferase (GST) tag (Invitrogen), by an LR reaction. All
clones were full-length sequence-veriﬁed (Supplementary Data 1).
Custom PBM design. Target sites for each TALE protein were determined using
the canonical TALE code (NI: A, HD: C, NN: G, NG: T), and are preceded by the
50 T to create the full target site. The constant ﬂanking regions were the same as
that used in a prior custom PBM design and do not contain binding sites for any of
the TALE proteins in this study44. Probe set descriptions, including the array
design versions on which they are included, are provided in Supplementary Note 1.
PBM experiments. Proteins were expressed using the PURExpress In Vitro
Transcription and Translation Kit (New England Biolabs). Protein concentrations
were determined by anti-GST western blots with a dilution series of recombinant
GST (Sigma). Proteins were stored at þ 4 C until being used in PBM assays. PBMs
were performed as follows:29 brieﬂy, custom-designed microarrays were ﬁrst
double-stranded by an on-slide primer extension reaction. In the PBM assay, arrays
were blocked with 2% milk in PBS for 1 h, washed with 0.1% Tween-20 in PBS and
0.01% TX-100 in PBS, then incubated with protein mixture (PBS, 2% milk,
0.2mgml 1 BSA and 0.3 mgml 1 salmon testes DNA) for 1 h. The ﬁnal
concentration of TALE protein in the PBM reactions was 200 nM, unless otherwise
indicated (Supplementary Table 1). Arrays were washed with 0.5% Tween-20 in
PBS and 0.01% TX-100 in PBS. Lastly, the array was incubated for 30min with an
Alexa488-conjugated anti-GST antibody (Invitrogen A-11131), and washed with
0.05% Tween in PBS and PBS.
PBM data quantiﬁcation. PBM arrays were scanned using a GenePix 4400A
Microarray Scanner (Molecular Devices), and scan images were analysed by
GenePix Pro (Molecular Devices). Raw data ﬁles were processed using the same
general approach as used for universal PBMs29. Brieﬂy, masliner software45 was
used to combine Alexa488 scans at three different laser power levels and to resolve
the signal intensity in spots that are saturated at high laser power settings. Cy3
scans were performed at a single laser power level. If a data set had any negative
background-subtracted intensity (BSI) values (which can occur if the region
surrounding a spot is brighter than the spot itself), a pseudocount was added to all
BSI values for that experiment such that all values were then positive. The adjusted
BSI data were then normalized by the corresponding double-stranded DNA
content of the spots and their position on the array using the same approach as
described for universal PBMs29. To normalize by the relative amount of double-
stranded DNA per array spot, small quantities of Cy3-dUTP were added to the
nucleotide pool during the double-stranding process. The BSIs on the Cy3 channel
can therefore be used to estimate relative DNA abundance at each spot. However,
because Cy3 incorporation depends on the local sequence context, we used a
linear regression over the trinucleotides present in a given probe to calculate the
expected Cy3 BSI and obtain the expected-to-observed ratio30. This ratio is then
used to normalize the Alexa488 BSIs to account for difference in relative amounts
of double-stranded DNA. Any probes with BSIs that were corrected by more than
twofold or for which the adjustment would lead to a negative BSI value were
removed from the data.
All PBM designs include at least eight replicate probes for each sequence. For
each experiment and for each set of probes with identical sequences, we calculated
the median-adjusted BSI, median absolute deviation (MAD) and the robust standard
deviation estimate from the MAD. Any individual replicate probe with a normalized
adjusted BSI value more than 3 s.d. away from the median of the replicate probes
was omitted from subsequent analysis, to avoid confounding statistical tests or
incorrect choice of parameter settings in model ﬁtting.
For each TALE protein, we deﬁned a background set of probes that comprises
all the probes on the array designed to represent binding sites for other TALE
proteins (not the one being assayed in a given experiment). The array median level
was then calculated as the median normalized adjusted BSI of all probes in the
background set. The standard deviation of the background set SIs was calculated
robustly using the asymptotic approximation s¼ 1.4826MAD. The z-score for
each probe was calculated relative to the median and standard deviation of its
corresponding background probes. These z-scores represent a linear
transformation of the median SIs for each probe, and therefore facilitate
interpretation but do not affect the PWM ﬁtting procedure, which performs its
own linear scaling adjustments.
PWM model ﬁtting. We developed a Bayesian Markov chain Monte Carlo
(MCMC) method to infer free energy parameters of TALE–DNA interactions from
PBM data. We relied on the theoretical framework developed for the BEEML-PBM
algorithm36, which can accurately derive DDG values for protein–DNA contacts
from universal PBM experiments. The BEEML-PBM framework estimates DDG
values for each possible nucleotide substitution in a protein’s DNA-binding site
motif. These values can be assembled to construct an energy matrix (EM), in which
each column represents a position within the binding site and each row represents
a nucleotide. The EM values can be converted to probabilities using the Boltzmann
distribution, creating a PWM.
Brieﬂy, the goal is to predict the observed probe signal intensity z-scores as a
function of the binding site sequence within the probe. As an intermediate step, the
DDG values are used to predict occupancy of the TALE protein on its binding site.
The predicted occupancy is then scaled linearly to optimally scale with the
observed z-scores. The chemical potential (log([TF]/Kd) was also included in the
model and can account for differences in TALE protein concentration and afﬁnity
to the optimal binding site. The statistical model is described in full in
Supplementary Methods. At each sampling step, the probe z-scores are predicted
given the current parameter values, which can be used to derive 95% credible
intervals46, as shown in Fig. 2a. The priors on DDG values were set as exponential
distributions with mean 10.0 to cause the preferred base to adopt values close to 0
but to not signiﬁcantly penalize larger parameter values for other bases. The rest of
the parameters were given a uniform prior.
To perform MCMC sampling, we used the No-U-Turn Sampler included in
Rstan v2.0 with default parameter settings. The DDG parameters were initialized
following a simple TALE code: DDG¼ 0.0 for the predicted optimal base at a given
position, DDG¼ 3.0 otherwise (in units of kT/RT). For each data set, we obtained
500 parameter samples in the burn-in period followed by 2,000 samples that were
used to approximate the posterior distributions of all parameters. Four MCMC
chains were run in parallel for each data set; the samples from each chain were then
used to verify convergence of all DDG parameters (Gelman-Rubin convergence
statistic for all four chains o1.05). Note that sampling is more efﬁcient in
Hamiltonian MCMC methods (such as No-U-Turn Sampler) and thus fewer
iterations are required than in standard MCMC methods, such as Gibbs
sampling47.
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SIFTED predictive model for DDG values. The DDG values inferred from the
TALE PBM experiments were used to train a predictive model using an Elastic Net
regression34. The energy term for each inferred protein–DNA contact (that is, each
repeat contacting each of the four possible nucleotides) represents a single
observation. However, each column in the EM has only three degrees of freedom,
since adding a constant value to all terms does not change the resulting PWM.
Therefore, each EM derived from the data was ﬁrst adjusted by adding a constant
value to each column such that the preferred base has a DDG of exactly 0 (because
of the exponential prior described above, these values are already close to 0 when
the repeat binds its expected base preferentially). These zero-valued DDG terms
were then removed from the data set, leaving only the values for the non-preferred
bases as input.
The full predictive feature matrix was normalized such that each column had
mean zero and unit variance. Numerical features (for example, total length of the
target site) are included directly in the feature matrix. In the case of categorical
features (for example, RVD identity), we created binary indicator variable columns
(‘dummy variables’) representing each potential categorical value. We used
regression weights to reduce the biases that could be created by having an unequal
number of proteins of different lengths. Each squared error term in the Elastic Net
objective function was multiplied by the weight corresponding to that observation.
The observations corresponding to a given protein were assigned a weight of
1/(# of proteins of the same length).
We used the Elastic Net implementation in the glmnet v1.9-5 R package to train
our model. The Elastic Net is a regularized regression method that seeks to penalize
models that are too complex (that is, have too many parameters) and thus prevent
overﬁtting34. The Elastic Net objective combines the penalty terms used in L1
(or LASSO) and L2 (or Ridge) regressions. Here, we set the balance between the two
terms to 95% L1 penalty and 5% L2 penalty, favouring the sparseness of the L1
method but also keeping some of the advantages of the L2 method, such as the
uniqueness of solutions.
Each DDG in the data set is paired with a vector of predictive features to create
the feature matrix, in which each row is an independent observation, and each
column is a different feature. The features include repeat identity, position,
neighbouring repeat identity and total length of the target site. Numerical features
(for example, total length of the target site) are included directly in the feature
matrix. In the case of categorical features (for example, RVD identity), we created
binary indicator variable columns (‘dummy variables’) representing each potential
categorical value. To allow for non-linear position and length effects, we also
included the natural logarithm of each as a feature. The full predictive feature
matrix was normalized such that each column had mean zero and unit variance.
We used regression weights to reduce the biases that could be created by having an
unequal number of proteins of different lengths. Each squared error term in the
Elastic Net objective function was multiplied by the weight corresponding to that
observation. The observations corresponding to a given protein were assigned a
weight of 1/(# of proteins of the same length).
To prevent overﬁtting and to accurately assess the model’s performance, we
used a cross-validation scheme consisting of two nested levels. On the outer level,
we used leave-one-out cross-validation to form a validation set by excluding a
single protein in each iteration. Once a protein is excluded, the inner level performs
ﬁvefold cross-validation on the remaining 20 proteins. For 100 different values of
the Elastic Net penalty term l, we calculate the mean-squared error (MSE) on the
test set for the model obtained from the training set (Supplementary Fig. 6). For a
given value of l, the average MSE over all test sets is calculated. The l value that
minimizes the overall average MSE is then used for all subsequent predictions. This
is achieved by creating bootstrap estimates of the MSE at each value of lambda and
picking the simplest (that is, most penalized) model that performs within one
standard deviation of the model with the lowest average MSE (dashed vertical lines
in Supplementary Fig. 6). The model associated with the best l value was then used
to make predictions on the protein excluded in the outer loop; the same l value was
used for all training sets. This entire process is repeated for each protein, leading to
cross-validated predictions for the entire data set. These predictions were then used
for all model evaluation purposes.
Predicting probe signal intensities and Kd values from PWMs. The predictions
of probe signal intensities were obtained using the same mathematical framework
as for ﬁtting PWMs (Supplementary Methods). However, in this case, the DDG
parameters are known and the only parameters that need to be ﬁtted to predict
probe intensities are the chemical potential m and the scaling terms a and b. To
determine these parameters, we used the implementation of the Levenberg–
Marquardt algorithm in the SciPy v0.12 package with default convergence para-
meters. The model parameters were initialized as follows: a¼minimum z-score in
input data, b¼maximum z-score in input data, m¼  1.0. After these parameters
were ﬁtted from the observed z-scores, the predicted z-scores were obtained by
using the total DDG for the binding site in each probe and the ﬁtted variables as
input.
To validate SIFTED predictions with measured Kd values35, relative Kd values
for target and off-target sites were predicted from SIFTED PWMs. Relative Kd
values were predicted by setting the Kd of the optimal site to 1. The predicted Kd
values for off-target sequences were obtained through the equation eDDG/RT, where
DDG represents the difference in total free energy between the optimal binding site
sequence and the sequence of the off-target site. The measured relative Kd values
were similarly adjusted so that the optimal site had a Kd of 1. Because Kd values
span many orders of magnitude, the correlation coefﬁcient was computed after
taking the natural logarithm of the Kd values, which prevents the calculation from
being dominated by the extreme values.
Comparison using PWMs from other tools. PROGNOS, TALgetter, Talvez and
TALE-NT 2.0, the publicly available tools against which we compared SIFTED, do
not explicitly provide the user with predicted PWMs23,24,27,28. However, with the
exception of TALgetter, each tool uses an internal scoring scheme that is
mathematically equivalent to a PWM (that is, the score for a site represents the
sum of an independent score for each nucleotide position). Therefore, in the
comparisons with PROGNOS, Talvez and TALE-NT 2.0, we predicted PWMs
based on the scheme described by each paper and the associated parameters23,27,28.
To predict TALgetter scores, we instead used the downloadable TALgetter software
tool to compute log-odds values for all binding site sequences in a given
experiment24. These binding scores can then be compared directly to PWM log-
odds scores, even if the underlying scoring scheme is distinct. For comparisons
using TALEN activity data, we combined the values predicted by PWMs for each
TALE in a TALEN pair using the same scoring scheme as PROGNOS27. Here, the
scores S are obtained by taking the negative natural logarithm of each value in the
PWM, creating a value that becomes larger the more disfavoured a particular
nucleotide is at a particular position. Then, we compute the ratio of the score S
summed over the optimal target site and the score S summed over the potential off-
target site being analysed. These ratios are elevated to an exponent (0.6, as
determined to be optimal by Fine et al.27). Finally, the partial score for each
member of the TALE pair is added to create a ﬁnal score, as in the equation below.
Pairscore ¼ Sleftðoptimal siteÞ
Sleftðtarget siteÞ
 0:6
þ Srightðoptimal siteÞ
Srightðtarget siteÞ
 0:6
ð1Þ
We analysed the TALEN target sites reported by Guillinger et al.20. We scored each
reported target site that contained only NN, NI, HD, and NG RVDs using the
TALEN Pair Score derived from the PWMs obtained from SIFTED, PROGNOS
and TALE-NT 2.0. We summarized the performance of each tool as a receiver
operating characteristic curve, which shows the sensitivity and speciﬁcity values
achieved by each tool when predicting sites that were targeted by the TALEN pairs.
The different sensitivity and speciﬁcity values represent different Pair Score
thresholds, above which a locus is predicted to show evidence of nuclease activity
(indels).
We also compared against the TALE activator reported by Mali et al22. All of
the reported binding sites up to three mismatches away from the predicted site
were scored as described above. These scores were then compared with a
normalized expression score (the ratio of barcode tags for that binding site relative
to a control experiment) associated with that binding site—TALE combination. As
we expect the relationship between TALE occupancy and expression to be
nonlinear, we compared the results using Spearman correlation.
Algorithmic approach of SIFTED web tool. The overall approach of the entire
pipeline to identify and score candidate TALEs to target a genomic region is as
follows: ﬁrst, candidate TALE-binding sites within the user-input DNA sequence
are identiﬁed. For each site found, the protein that targets that sequence is
determined using the TALE code, and its PWM is predicted. For each protein, the
PWM is used to enumerate all putative binding site sequences (both target and off-
target sequences) with a relative Kd threshold (by default, set to 10), using a
bounded breadth-ﬁrst search. All genomic instances of the putative binding site
sequences are found using a short read aligner (bowtie). Finally, a summary score is
calculated for each protein that describes the overall number and strength of
genomic target sequences. Under default parameter settings (for example, 13.5
repeat TALE, 1-kb region), the SIFTED pipeline typically identiﬁes optimal TALE
candidates within minutes. In addition, a user can input a TALE with a deﬁned
RVD sequence, and SIFTED will predict its speciﬁcity and identify potential
genomic off-target sites. Tutorials are hosted on the SIFTED website (http://
thebrain.bwh.harvard.edu/sifted.html) for designing TALEs to target a region, and
for predicting the speciﬁcity of a pre-designed TALE, and include additional
guidelines for setting parameters and troubleshooting. For more details on the
algorithmic approach, see Supplementary Methods.
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